Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke (DASH)

May 15, 2026 updated by: Bruyère Health Research Institute.

Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke: An Effectiveness-implementation Hybrid Trial.

The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:

  1. After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors?
  2. Does the effects of the volunteer support last over 3 to 6 months after being discharged home?

Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.

Participants will:

  • Either receive volunteer support over an 8-week time period OR receive no additional volunteer support
  • Continue with their usual care plan and receive educational resources from the research team during the study
  • Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge

Study Overview

Detailed Description

Acute stroke often leads to adult disability in Canada, and about 108,707 Canadians experience a stroke each year. While most people survive stroke (80 percent) and return home, some survivors are left with ongoing challenges that require them to seek help in the community. These challenges can lead to stress for the individual and their caregiver. Research on volunteer-supported home-to-hospital programs has shown positive outcomes. However, despite the growing evidence that supports volunteer engagement in care transitions, we have yet to determine the impact of a complex psychosocial volunteer-delivered care transition intervention for stroke survivors. This study will assess whether a volunteer-delivered transitional care intervention, designed by Bruyère Health Research Institute in partnership with March of Dimes Canada (MODC), for adults discharged home from a stroke rehabilitation unit following an acute stroke can improve coping compared to usual care. MODC will implement the volunteer-support transition program across two Ontario regions for stroke rehabilitation sites. Those allocated to the intervention group will receive an initial visit from the Volunteer Coordinator and then weekly one-on-one visits by a trained volunteer for eight weeks. The volunteer may assist the study participant with instrumental daily living activities and psychosocial and informational support. Those not receiving the intervention will receive educational material at 4- and 8-week time points in addition to their usual care. All study participants will complete validated patient-reported outcome measures at 3- and 6-months post-hospital discharge.

Study Type

Interventional

Enrollment (Estimated)

840

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ontario
      • Ottawa, Ontario, Canada
        • Bruyère Health Élisabeth-Bruyère Hospital
      • Toronto, Ontario, Canada
        • Sunnybrook Health Sciences Centre
      • Toronto, Ontario, Canada
        • Hennick Bridgepoint Hospital
      • Toronto, Ontario, Canada
        • Providence Healthcare (Unity Health Toronto)
      • Toronto, Ontario, Canada
        • Toronto Rehabilitation Institute (UHN)
      • Toronto, Ontario, Canada
        • West Park Healthcare Centre (UHN)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Confirmed diagnosis of stroke
  • Either undergoing or recently completed in-patient rehabilitation within the last 3 weeks
  • Lived at home pre-stroke
  • Discharged directly home (to own residence or that of a family member)
  • Live in one of the program implementation areas (i.e., Toronto, Ottawa)

Exclusion Criteria:

  • Discharged to additional hospital inpatient care, nursing home, or other long-term care
  • Inability to communicate in English
  • Inability to provide informed consent due to cognitive deficits

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A: DASH group
Participants will receive the DASH intervention + Usual Care + Educational Resources

One-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types:

i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services).

No Intervention: Group B: Usual care group
Participants will receive the Usual Care + Educational Resources

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Time Frame: Measured at 3 months post-hospital discharge
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported outcome measure evaluating perceived difficulty coping following hospital discharge. Each item is scored on a scale from 0 to 10. Item scores are summed to yield a total score ranging from 0 to 100, with higher scores indicating greater difficulty coping.
Measured at 3 months post-hospital discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in coping as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Time Frame: Measured at 3 months and 6 months post-hospital discharge
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported measure. Each item is scored from 0 to 10, with total scores ranging from 0 to 100. Change in total score will be calculated between time points. Higher scores indicate greater difficulty coping.
Measured at 3 months and 6 months post-hospital discharge
Change in quality of life as assessed by Stroke-Specific Quality of Life (SS-QOL)
Time Frame: Measured at 3 months and 6 months post-hospital discharge
Quality of life will be assessed using the Stroke-Specific Quality of Life (SS-QOL) scale, a 49-item patient-reported measure evaluating multiple domains of health-related quality of life in stroke survivors. Each item is scored on a 5-point Likert scale (1 to 5). Domain scores are calculated as the average of items within each domain, and the overall score is calculated as the average of all domain scores or as the sum of all 49 items (ranging 49 to 245). Higher scores indicate better quality of life.
Measured at 3 months and 6 months post-hospital discharge
Change in symptoms of depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Measured at 3 months and 6 months post-hospital discharge
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported measure. Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
Measured at 3 months and 6 months post-hospital discharge
Change in social isolation and loneliness indicators as assessed by UCLA Loneliness Scale (Version 3)
Time Frame: Measured at 3 months and 6 months post-hospital discharge
Social isolation and loneliness will be assessed using the UCLA Loneliness Scale (Version 3), a 20-item patient-reported measure evaluating subjective feelings of loneliness and social isolation. Each item is scored on a 4-point scale. Total scores range from 20 to 80, with higher scores indicating greater loneliness.
Measured at 3 months and 6 months post-hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

April 1, 2028

Study Registration Dates

First Submitted

May 11, 2026

First Submitted That Met QC Criteria

May 11, 2026

First Posted (Actual)

May 15, 2026

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 15, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Discharge Assistance and Supports at Home (DASH)

Subscribe